The CenterWatch Monthly, April 2012
Global sites see growth in trials, revenue, staffing
Global investigative sites saw encouraging signs of financial recovery during the past year, according to new CenterWatch data, with the average site reporting growth in clinical trial activity, site staff, patient volume and revenue. While clinical trial activity is expected to increase another 10% in 2012, sites remain wary about the lingering effects of the global economic crisis and the majority won’t expand operations this year. Sites also reported an improvement in cash flow and a rebound in…
Industry struggles with prospect of trials leaving U.S.
As the clinical trials industry continues to expand around the globe, some industry leaders have begun questioning whether action is needed to keep more trials in the United States. Should the FDA have a quota for what percent of trials are conducted in the U.S.? Should other regulations or incentives be used to staunch the flow of trials to developing nations? Does it matter whether or not the patient population comes from the U.S.? Last October, Duke University hosted “Rescuing Clinical Trials in the U.S.: A Call for Action,” an effort to spur the conversation among high-level industry…
Eye on Lundbeck
Copenhagen, Denmark-based Lundbeck aims to become a world leader in psychiatry and neurology, and improve the quality of life of people suffering from disorders in these areas, by developing and providing innovative specialty therapies. The company’s focused expertise, global resources, extensive academic and institutional research network, and reputation for effective partnering make it a logical choice for…
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.